Press release
Lupus Nephritis - Drug Pipeline Landscape, 2022 | Corestem Inc, Eledon Pharmaceuticals Inc, Equillium Bio, Hoffmann-La Roche Ltd
Lupus Nephritis
Lupus Nephritis is an autoimmune kidney disease caused by systemic lupus erythematosus (SLE). It is a type of glomerulonephritis where autoantibodies affect the structures of glomeruli which results in inflammation and decreased kidney output.
Lupus Nephritis is mainly of 6 types, following minimal mesangial glomerulonephritis, mesangial proliferative glomerulonephritis, focal glomerulonephritis, diffuse proliferative nephritis, membranous glomerulonephritis and advanced sclerosing lupus nephritis.
View Detailed Report Description : https://www.globalinsightservices.com/reports/lupus-nephritis-drug-pipeline-landscape-2022/
The main cause of the lupus nephritis is the genetic predisposition, and environmental triggers interplay. The other cause is damage of the kidneys and harming their ability to filter out waste due to the immune system proteins caused by systemic lupus.
General signs and symptoms of lupus nephritis is high blood pressure, edema, malar rash, foamy urine, fatigue, joint pain, fever, blood in urine, protein in urine and impaired kidney function.
The diagnosis of lupus nephritis includes blood tests, urinalysis, X-rays, ultrasound scans of the kidneys and kidney biopsy.
The main goal in the treatment of lupus nephritis is to reduce symptoms, maintain remission, and avoiding the need for dialysis. The drug regimen includes anti-hypertensive agents, immunosuppressive agents, corticosteroids, and diuretics.
Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS31044
Report Highlights
Global Insight Service's, Lupus Nephritis - Drug Pipeline Landscape, 2022 report provides an overview of the Lupus nephritis pipeline drugs. This report covers detailed insights on Lupus Nephritis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lupus Nephritis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Purchase your copy now : https://www.globalinsightservices.com/checkout/single_user/GIS31044
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Key Players
Alexion Pharmaceuticals
Ampio Pharmaceuticals Inc
Asahi Kasei Pharma Corporation
AstraZeneca
BeiGene Inc
BioAegis Therapeutics Inc
Boehringer Ingelheim
ChemoCentryx Inc
Corestem Inc
Eledon Pharmaceuticals Inc
Equillium Bio
Hoffmann-La Roche Ltd
Genentech Inc
Request For Customization : https://www.globalinsightservices.com/request-customization/GIS31044
Reasons to buy Lupus Nephritis Report:
• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Nephritis - Drug Pipeline Landscape, 2022 | Corestem Inc, Eledon Pharmaceuticals Inc, Equillium Bio, Hoffmann-La Roche Ltd here
News-ID: 2796417 • Views: …
More Releases from Global Insight Services
Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFL …
The Liver Disease Treatment Market continues to expand rapidly as global awareness, early diagnosis, and advanced therapeutic approaches reshape patient care. With the market valued at $26.6 billion in 2024 and projected to reach $44.8 billion by 2034 at a steady 5.4% CAGR, demand for effective and accessible therapies is on the rise. The Liver Disease Treatment Market covers pharmaceuticals, biologics, vaccines, diagnostics, and liver transplant services designed to manage…
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing o …
The Healthcare Supply Chain BPO Market is rapidly evolving as healthcare providers worldwide seek smarter, leaner, and more resilient operations. With growing pressure to reduce costs, boost efficiency, and maintain uninterrupted patient care, outsourcing supply chain tasks has become a strategic necessity. The global Healthcare Supply Chain BPO Market is projected to grow from $3.05 billion in 2024 to $4.83 billion by 2034, reflecting a CAGR of 4.7%. This expansion…
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Servic …
Market Overview
Robotics Crawler Camera System Market is witnessing a major transformation as industries shift toward advanced inspection technologies that improve safety, accuracy, and operational efficiency. These robotic crawlers, equipped with high-resolution cameras and strong maneuverability, enable real-time inspection across pipelines, sewers, industrial tanks, and hazardous environments where manual inspections pose risks. As automation becomes central to industrial maintenance, the Robotics Crawler Camera System Market continues to gain momentum, supported by…
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veteri …
Market Overview
Pet DNA Testing Market is rapidly transforming the way pet owners understand the health, ancestry, and traits of their companion animals. As pets increasingly become family members, owners are demanding deeper insights into their pets' genetic makeup. The Pet DNA Testing Market offers services such as breed identification, disease risk assessments, trait analysis, and ancestry mapping. With advancements in genomics and the expansion of direct-to-consumer testing kits, the Pet…
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
